General Information
| Short Description | Cho Cells monoclonal anti-Recombinant-SARS-CoV-2 Spike RBD for use in ELISA in SARS-CoV-2 samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | ELISA |
| Host | CHO cells |
| Reactivity | SARS-CoV-2 |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | 6G7 |
| Isotype | IgG1 kappa |
| Conjugation | Unconjugated |
| Purification | Protein A affinity chromatography following desalting |
| Dilution Range | Indirect ELISA 0.08 – 0.16 ng/ml |
| Formulation | PBS pH 7.4 |
| Storage Instruction | Store at-20 °C to-70 °C long term. Avoid multiple freeze-thaw cycles. |
| Dissociation Constant | < 1.0 x 10-12 M (measured against SARS-CoV-2 Trimeric Spike protein) 1.66 x 10-8 M (measured against SARS-CoV-2 Spike S1 protein) |
Target Information
| Immunogen | SARS-CoV-2 virus (PBMCs isolated from patients recovered from SARS-CoV-2 infection, antibodies) |
| Specificity | SARS-CoV-2 Spike RBDNeutralizing properties: blocks S1 and ACE2 binding in Octet system; IC50 5000 ng/ml measured in live virus neutralization assay |